Navigation Links
Stem Cells In Sports Injuries, Joints And Muscular Pain
Date:7/24/2014

COSTA MESA, Calif., July 24, 2014 /PRNewswire/ -- Now available is a stem cell therapy that is incredibly close to home. Rehealth Regenerative Therapies, located in Guadalajara, Mexico, is offering athletes and other physically active people a new health option: stem cell therapies for sports injuries.

Regardless of age, countless patients suffer from joint and muscle injuries due to professional or amateur sport activities, such as muscle tears, torn rotator cuff, tennis elbow, and knee injuries. Throughout life these types of injuries can occur and constitute a severe problem for functional disability and pain.

Conventional medicine for joint and muscular pain includes the use of pain-killers, anti-inflammatory drugs, steroids or local medication. These treatments all come with side effects such as gastritis, gastrointestinal bleeding, renal or hematologic toxicity, yet do not solve the issue at hand.

Within the past decade, the use of stem cells for sports injuries has increased. According to the article, Emerging Applications of Stem Cell and Regenerative Medicine to Sports Injuries by Ajibade et al, "Cell-based therapies and regenerative medicine offer safe and potentially efficacious treatment for sports-related musculoskeletal injuries."

Why stem cells for sports injuries?

Due to many reasons, as we age, our body does not have the natural ability to repair itself. Following trauma or injury, the body immediately tries to repair itself, yet the majority of these sports injuries occur in cells or tissue that have very limited regenerative capabilities.

Cells from the immune system, biochemical substances and molecules are released into the blood stream to clean the area from the dead cells' debris, bring other cells to repopulate the zone, regenerate the tissue and finally, make a scar.

Throughout this long process there would be pain, not only due to the lesion itself (i.e.: an ankle sprain), but also due to the inflammation that is launched to heal the damage.

Stem cell therapy may address all these concerns. First, stem cells have properties that can control inflammation (immunoregulation). Second, they release growth factors that can stimulate the production of other cells needed to repair the tissue (wound healing). Third, they can increase vasculature (blood flow) to the area, which increases healing. Finally, they may replace damaged cells. While stem cells are not analgesics, they may soothe joint and muscle pain by acting on the causes that provoke it. Therefore, treating the cause directly controls a symptom, such as pain.

How are they applied?

For sports injuries, stem cell procedures are usually performed under local anesthesia that may be complemented by a light sedation according to the patient's condition. The majority of these procedures are ambulatory, which means that patients are usually discharged the same day. The stem cells are normally directly injected into the targeted areas. In cases such as osteoarthritis this may avoid the need for a joint replacement.

ReHealth Regenerative Therapies

ReHealth is a stem cell therapy center located in Guadalajara, Mexico, where a team of physicians and scientists, with years of experience in Cellular Therapy, is dedicated to improving the quality of life of their patients.  

Rehealth has combined their stem cell therapy expertise with the technical knowledge of DaVinci Biosciences, a biotechnological research lab based in Costa Mesa, CA, USA to become one of the most well known therapy centers amongst patients and the stem cell community.

Based on COFEPRIS approved protocols for stem cell applications, Rehealth thoroughly analyzes each case. Let us evaluate your case and determine if you are a candidate for our stem cell therapy. Visit our website, www.Rehealth.com, today to get started.


'/>"/>
SOURCE ReHealth Regenerative Therapies
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. How NSG Precision Cells Spectrophotometer Calibration Standards Makes NIR Work Easier
2. Global Market for Induced Pluripotent Stem Cells to Reach $2.9 Billion in 2018; Technology Offers New Hope for Regenerating Human Tissue
3. Molecular eat now signal makes cells devour dying neighbors
4. Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells
5. Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc.
6. Aging Population & Rising Incidence of Chronic Diseases to Drive the Global Mesenchymal Stem Cells Market, According to New Report by Global Industry Analysts, Inc.
7. JDRF and Brehm Center Partner to Explore the Fate of Beta Cells in Type 1 Diabetes
8. Biomaterials get stem cells to commit to a bony future
9. Piggy-backing proteins ride white blood cells to wipe out metastasizing cancer
10. Cells from the eye are inkjet printed for the first time
11. Quantum waves at the heart of organic solar cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... KONG, Feb. 24, 2017 China Cord Blood Corporation ... China,s leading provider of cord blood collection, laboratory testing, ... today announced its unaudited financial results for the third ... ended December 31, 2016. Third Quarter of ... third quarter of fiscal 2017 increased by 18.6% to ...
(Date:2/24/2017)... VWR), the leading global independent provider of product and service ... results for the fourth quarter and full year ended December ... record quarterly net sales of $1.13 billion, up 1.6% year-over-year, ... 4Q16 EMEA-APAC segment net sales increased 0.4%, up ... increased 2.5%, or down 0.9% on an organic basis, driven ...
(Date:2/23/2017)... Financial Highlights (in ... Months Ended December 31,Twelve Months Ended December 31,20162015% ... $           300$     ... Revenue 3539(10)%9498(4)%Kuvan Net Product Revenue ... 756025%297303(2)%Vimizim Net Product Revenue ...
(Date:2/23/2017)... 2017  MIODx announced today that it has ... technologies from the University of California, San Francisco ... monitor a patient for response to immune checkpoint ... second license extends the technology with a method ... have an immune-related adverse event (IRAE) from their ...
Breaking Biology Technology:
(Date:2/8/2017)... AWRE ), a leading supplier of biometrics software ... year ended December 31, 2016. Revenue for ... $6.9 million in the same quarter last year. Operating income ... to $2.6 million in the fourth quarter of 2015. Net ... or $0.02 per diluted share, which compares to $1.8 million, ...
(Date:2/8/2017)... The biometrics market has reached a ... organizations, desires to better authenticate or identify users ... challenge questions), biometrics is quickly working its way ... is driven by use cases, though there traditionally ... uses cases, with consumer-facing use cases encompassing authentication, ...
(Date:2/7/2017)... 2017   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that the latest ... highly flexible and award winning eClinical solution, is now ... is a proven Software-as-a-Service (SaaS) clinical research technology ... but also delivers an entire suite of eClinical tools ...
Breaking Biology News(10 mins):